Study identifies genetic mutations associated with cancer risk for hereditary cancer syndrome
(Medical Xpress) -- Among various genetic mutations for individuals with Lynch syndrome, a hereditary cancer syndrome that carries a high risk of colon cancer and an above-normal risk of other cancers, researchers have identified mutations associated with a lower cancer risk and mutations associated with an increased risk for ovarian and endometrial cancer, according to a study in the June 8 issue of JAMA, a theme issue on cancer.
The Lynch syndrome, also known as hereditary nonpolyposis colorectal cancer syndrome, accounts for 3 percent to 5 percent of all colorectal cancers. "Providing accurate estimates of cancer risks is a major challenge in the clinical management of Lynch syndrome," according to background information in the article. "Having more accurate knowledge of the age-dependent cancer risks associated with mismatch repair [MMR; a system within the cell for correcting errors in DNA] gene mutations would help in improving preventive strategies."
Valerie Bonadona, M.D., Ph.D., of the Centre National de la Recherche Scientifique, Villeurbanne, France, and colleagues conducted a study to estimate the specific cancer risks associated with mutations in the genes MLH1, MSH2, and MSH6 by analyzing a large sample of families with Lynch syndrome. The study included 537 families with segregating mutated genes (248 with MLH1; 256 with MSH2; and 33 with MSH6). The families were enrolled between January 2006 and December 2009 from 40 French cancer genetics clinics.
The researchers found significant differences in estimated cumulative cancer risk between the 3 mutated genes. "For colorectal cancer, the estimated cumulative risks by age 70 years were 41 percent for MLH1 mutation carriers, 48 percent for MSH2, and 12 percent for MSH6. The estimated cumulative risks in carriers did not begin to increase until age 30 years, irrespective of gene mutation. For endometrial cancer, the estimated cumulative risks by age 70 years were 54 percent for MLH1, 21 percent for MSH2, and 16 percent for MSH6. By age 40 years, the estimated cumulative risk did not exceed 2 percent, irrespective of gene mutation. For ovarian cancer, the estimated cumulative risks by age 70 years were 20 percent for MLHl, 24 percent for MSH2, and 1 percent for MSH6. By age 40 years, the estimated cumulative risk did not exceed 1 percent, irrespective of gene mutation."
"These results contribute new complementary data to the discussion of preventive gynecological care. Clinical guidelines state that prophylactic gynecological surgery should be considered in women with Lynch syndrome," the authors write. "Our findings should help in identifying more precisely the target population for surgery and address the issue of optimum age."
For other Lynch syndrome-associated cancers, the estimated cumulative risks by age 70 years did not exceed 3 percent overall and were consistently lower among families with the MSH6 mutations than in those carrying the other gene mutations.
"This analysis of a nationwide series of 537 families with Lynch syndrome provides age- and gene-specific risk estimates for each tumor of the spectrum. The results should help clarify the phenotypic differences between MSH6, MLH1, or MSH2 mutation carriers and highlight the clinical significance of the risk of gynecological (and especially ovarian) cancers," the researchers conclude.
More information: JAMA. 2011;3052304-2310
Provided by JAMA and Archives Journals
- High risk of colorectal, endometrial and Lynch syndrome cancers for MSH6 mutation carriers Dec 22, 2009 | not rated yet | 0
- Model Predicts Colon Cancer Inheritable Genetic Defects Sep 27, 2006 | not rated yet | 0
- Inherited cancer mutation is widespread in America Apr 17, 2008 | not rated yet | 0
- The Medical Minute: Family tree one factor in colorectal cancer risk Mar 16, 2011 | not rated yet | 0
- New Mayo Clinic test targets Lynch syndrome, a risk factor for colon cancer May 18, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013 Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
In recent years, microRNAs (miRNAs) and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers. miRNA profiles have been used ...
Cancer 2 hours ago | not rated yet | 0
Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ...
Cancer 2 hours ago | not rated yet | 0
Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.
Cancer 5 hours ago | 5 / 5 (1) | 0
Transformative research from Western University has identified new hormones in the body which may suppress breast cancer and stimulate the regression of breast tumors.
Cancer 6 hours ago | 5 / 5 (1) | 0
(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.
Cancer 6 hours ago | 5 / 5 (3) | 0
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
36 minutes ago | not rated yet | 0 |
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
4 minutes ago | not rated yet | 0
(AP)—Government health officials are investigating several health problems reported with potentially contaminated medications made by a Tennessee specialty pharmacy.
30 minutes ago | not rated yet | 0
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
6 hours ago | 5 / 5 (3) | 0 |
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
3 hours ago | 5 / 5 (1) | 0 |
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
3 hours ago | 5 / 5 (2) | 0 |